Atorvastatin repurposing for the treatment of cryptosporidiosis in experimentally immunosuppressed mice

Bibliographic Information
Authors: Madbouly Taha N.; Salah A. Yousof H.-A.; El-Sayed S.H.; Younis A.I.; Ismail Negm M.S.
Journal: Experimental Parasitology
Publisher: Academic Press Inc.
Publication Date: October 2017
Volume / Issue: Volume 181
Pages: 57–69
ISSN: 144894
DOI: 10.1016/j.exppara.2017.07.010
Scopus: View on Scopus
PubMed: 28764965
Document Type: Article
Authors and Affiliations
Madbouly Taha N., Medical Parasitology Department, Kasr Al-Ainy School of Medicine, Cairo University, Egypt; Salah A. Yousof H.-A., Medical Parasitology Department, Kasr Al-Ainy School of Medicine, Cairo University, Egypt; El-Sayed S.H., Theodor Bilharz Research Institute, Imbaba, Giza, Egypt; Younis A.I., Medical Parasitology Department, Kasr Al-Ainy School of Medicine, Cairo University, Egypt; Ismail Negm M.S., Pathology Department, Kasr Al-Ainy School of Medicine, Cairo University, Egypt
Abstract
The present study was conducted on 200 male mice for the detection of the effect of Atorvastatin on Cryptosporidium spp. infection versus the commercially used drug Nitazoxanide in experimentally immunosuppressed mice. Atorvastatin was used alone at low dose (20 mg/kg), high dose (40 mg/kg), and combined with Nitazoxanide (1000 mg/kg) with either the low dose or high dose for five consecutive days. Parasitological assessment of the drug effect was done using Modified Z-N staining of stool samples collected from mice. Results revealed a reduction of the number of oocysts shed with percentage of reduction on the 21st day post infection by 53.7%, 67.2%, 70.1% & 77.5%, respectively, compared to the infected untreated group. The Nitazoxanide treated group showed 52.7% reduction. In addition, examination of small and large intestinal contents after mice scarification revealed reduced numbers of oocysts by 56.2%-58.8%, 65.1%-65.3%, 70.6%-73.9% and 77.8%-79.9%, respectively, compared to 51.2%-54.1% in Nitazoxanide treated group. The histopathological examination of sections from duodenum, jejunum, ileum, colon, stomach and lungs also revealed a significant improvement of the histopathological changes in Atorvastatin treated groups and more remarkable improvement in the groups treated with combined drugs as compared to infected untreated group. Accordingly, the combination of Atorvastatin and Nitazoxanide showed a synergistic effect through reduction of the number of oocysts shed and improvement of the histopathological changes induced by Cryptosporidium spp. infection in the small intestine, colon, stomach and lungs of infected immunosuppressed mice in comparison to that induced by either Nitazoxanide or Atorvastatin alone. © 2017 Elsevier Inc.
Keywords
Atorvastatin; Cryptosporidium; Drug effects; Histopathological assessment; Immunosuppressed mice; Nitazoxanide; Animals; Antiparasitic Agents; Atorvastatin Calcium; Colon; Cryptosporidiosis; Drug Synergism; Duodenum; Feces; Gallbladder; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ileum; Immunosuppression; Jejunum; Lung; Male; Mice; Stomach; Tablets; Thiazoles; antiparasitic agent; hydroxymethylglutaryl coenzyme A reductase inhibitor; tablet; thiazole derivative; animal experiment; animal model; animal tissue; Article; controlled study; dose response; drug effect; drug megadose; drug potentiation; drug structure; experimental mouse; feces analysis; gastrointestinal infection; histopathology; immune deficiency; intestine infection; low drug dose; lung infection; mouse; nonhuman; oocyst; priority journal; animal; immunology; immunosuppressive treatment; parasitology; pathology
Citation Information
Scopus Citations: 41
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
